Shuqin Zhang
Guangdong Provincial Key Laboratory Of Bone And Joint Degeneration Diseases
Guangzhou, 510630, China
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
5-O-Methylvisammioside, a novel inhibitor of CNT2, improves hyperuricemia by inhibiting intestinal purine nucleoside absorption with a safe profile.
Journal: Biochemical pharmacology
Published: May 23, 2025
Discovery of cyanidin-3-O-galactoside as a novel CNT2 inhibitor for the treatment of hyperuricemia.
Journal: Bioorganic chemistry
Published: October 15, 2024
Isobavachin alleviates hyperuricemia-induced bone loss by GPR35-NLRP3 signal.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 23, 2024
Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia.
Journal: Bioorganic chemistry
Published: March 03, 2024
Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity.
Journal: Bioorganic chemistry
Published: December 18, 2022
Enhancing autophagy and energy metabolism in the meniscus can delay the occurrence of PTOA in ACLT rat.
Journal: Frontiers in cell and developmental biology
Published: June 17, 2022
Mesenchymal stem cells plus bone repair materials as a therapeutic strategy for abnormal bone metabolism: Evidence of clinical efficacy and mechanisms of action implied.
Journal: Pharmacological research
Published: June 27, 2021
Dynamic alterations of spontaneous neural activity in patients with amyotrophic lateral sclerosis.
Journal: Brain imaging and behavior
Published: September 21, 2020
Application of mesenchymal stem cell exosomes and their drug-loading systems in acute liver failure.
Application of mesenchymal stem cell exosomes and their drug-loading systems in acute liver failure.
Journal: Journal of cellular and molecular medicine
Published: November 19, 2019
Pretreatment of exosomes derived from hUCMSCs with TNF-α ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage.
Journal: Life sciences
Published: October 09, 2019
Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acute liver failure by reducing the activity of the NLRP3 inflammasome in macrophages.
Journal: Biochemical and biophysical research communications
Published: November 21, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026